Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/5/26 16:30 | 1/1/26 | XLO | Health | Drug | Pharmaceutical Preparations | Luptakova Katarina | MA | O | CHIEF ME | 1 | M.d | 0 | 0.00 | 0 | 17 | 100 | 33 | D | ||||||||||||||
1/5/26 16:30 | 1/1/26 | XLO | Health | Drug | Pharmaceutical Preparations | Brennan Kevin M. | MA | O | SVP,FINA | 2 | M.d | 1 | 0.1720 | 0 | 7 | 6 | D | |||||||||||||||
1/5/26 16:30 | 1/2/26 | XLO | Health | Drug | Pharmaceutical Preparations | Brennan Kevin M. | MA | O | SVP,FINA | 2 | S.d | -1 | 0.1720 | 0 | -7 | 6 | D | |||||||||||||||
1/5/26 16:30 | 1/1/26 | XLO | Health | Drug | Pharmaceutical Preparations | Frankenfield Christopher James | MA | O | CFO | 2 | M.d | 5 | 0.1713 | 0 | 26 | 25 | D | |||||||||||||||
1/5/26 16:30 | 1/2/26 | XLO | Health | Drug | Pharmaceutical Preparations | Frankenfield Christopher James | MA | O | CFO | 2 | S.d | -5 | 0.1713 | 0 | -26 | 25 | D | |||||||||||||||
1/5/26 16:30 | 1/1/26 | XLO | Health | Drug | Pharmaceutical Preparations | Russo Rene | MA | DO | P,CEO | 1 | M.d | 0 | 0.00 | 0 | 44 | 16 | 325 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |